Literature DB >> 15932821

Prognostic value of echocardiography in peripartum cardiomyopathy.

Jeff B Chapa1, Heather B Heiberger, Lynn Weinert, Jeanne Decara, Roberto M Lang, Judith U Hibbard.   

Abstract

OBJECTIVE: To estimate whether echocardiography findings at the time of diagnosis of peripartum cardiomyopathy are predictive of persistent cardiac dysfunction.
METHODS: Chart review of patients with peripartum cardiomyopathy between 1988 and 2001 was performed. Data from echocardiography, including fractional shortening and left ventricular end diastolic dimension, were recorded both at the time of diagnosis and at follow-up. Left ventricular dysfunction was defined by echocardiography as fractional shortening less than 30% and left ventricular end diastolic dimension of 4.8 cm or more.
RESULTS: Of 32 patients meeting our definition for peripartum cardiomyopathy and for whom follow-up data were available, 13 (41%) had recovery of ventricular function, while 19 (59%) continued to have persistent left ventricular dysfunction. Those who did not recover cardiac function had a higher left ventricular end diastolic dimension and a lower fractional shortening at diagnosis than those who recovered. A fractional shortening value less than 20% and a left ventricular end diastolic dimension 6 cm or greater at the time of diagnosis was associated with a more than 3-fold higher risk for persistent left ventricular dysfunction.
CONCLUSION: Along with being an important diagnostic tool in peripartum cardiomyopathy, echocardiography may provide significant prognostic information with regards to recovery of cardiac function.

Entities:  

Mesh:

Year:  2005        PMID: 15932821     DOI: 10.1097/01.AOG.0000161382.30233.ba

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  36 in total

Review 1.  [The heart during pregnancy].

Authors:  Michael E Hall; Eric M George; Joey P Granger
Journal:  Rev Esp Cardiol       Date:  2011-10-01       Impact factor: 4.753

2.  Cardiac disease in pregnancy: value of echocardiography.

Authors:  Sarah Tsiaras; Athena Poppas
Journal:  Curr Cardiol Rep       Date:  2010-05       Impact factor: 2.931

Review 3.  Pathophysiology and epidemiology of peripartum cardiomyopathy.

Authors:  Denise Hilfiker-Kleiner; Karen Sliwa
Journal:  Nat Rev Cardiol       Date:  2014-04-01       Impact factor: 32.419

4.  Value of the neutrophil-to-lymphocyte ratio in predicting left ventricular recovery in patients with peripartum cardiomyopathy.

Authors:  Ufuk Gürkan; Haldun Akgöz; Şukru Aksoy; Özlem Can Gürkan; Altug Osken; Sennur Unal Dayi; Dilaver Oz; Recep Haci
Journal:  Wien Klin Wochenschr       Date:  2017-07-12       Impact factor: 1.704

Review 5.  Epidemiology and natural history of recovery of left ventricular function in recent onset dilated cardiomyopathies.

Authors:  Michael M Givertz; Douglas L Mann
Journal:  Curr Heart Fail Rep       Date:  2013-12

Review 6.  The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis.

Authors:  Natalie Bello; Iliana S Hurtado Rendon; Zoltan Arany
Journal:  J Am Coll Cardiol       Date:  2013-09-04       Impact factor: 24.094

Review 7.  Peripartum cardiomyopathy.

Authors:  Lori A Blauwet; Karen Sliwa
Journal:  Obstet Med       Date:  2011-05-12

Review 8.  Peripartum cardiomyopathy: A systematic review of the literature.

Authors:  Zain Ul Abideen Asad; Mirwais Maiwand; Fahmi Farah; Tarun W Dasari
Journal:  Clin Cardiol       Date:  2018-05-11       Impact factor: 2.882

9.  Peripartum cardiomyopathy: an intriguing challenge. Case report with literature review.

Authors:  Roberto Cemin; Rajesh Janardhanan; Massimo Daves
Journal:  Curr Cardiol Rev       Date:  2009-11

10.  Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study.

Authors:  Julie Damp; Michael M Givertz; Marc Semigran; Rami Alharethi; Gregory Ewald; G Michael Felker; Biykem Bozkurt; John Boehmer; Jennifer Haythe; Hal Skopicki; Karen Hanley-Yanez; Jessica Pisarcik; Indrani Halder; John Gorcsan; Sarosh Rana; Zoltan Arany; James D Fett; Dennis M McNamara
Journal:  JACC Heart Fail       Date:  2016-03-09       Impact factor: 12.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.